We recommend authors to publish their Animated Abstract, along with the article abstract, to extend the coverage of the published articles.
Bentham Science has collaborated with Focus Medica, one of the world's largest publishers of expert animated atlases and videos in medicine and science, to create an Animated Abstract of the article. Animated Abstracts will be published as open access (free-to-view) and help summarize the essential discoveries/key findings of the research, highlight the importance of the article for further research and utilization in the relevant industry. Each professionally produced, full-colored animated abstract, in video format (length 3 – 5 minutes) is accompanied by an English or foreign language commentary.
Authors can avail this service against a fee to get the Animated Abstract published with the textual / graphical abstract on the Journal's homepage (for reference, please visit: http://www.eurekaselect.com/video.html).
It will serve to define and gain attention for the article. For more information, please view the ‘Author Guidelines’.
Dr. Gross received a masters (M.S.) in Biology from the California State University and his doctorate (Ph.D.) in Cell Biology from the University of California, Los Angeles. He did his postdoctoral training at Tulane University School of Medicine. He has also done postgraduate programs at the Wharton School, Harvard/Tufts Law Schools and MIT. Dr. Gross is also faculty in the Jefferson College of Biomedical Sciences and the Sydney Kimmel Medical College of Thomas Jefferson University, Professor of Experimental Therapeutics and Medicinal Chemistry in the Blumberg Institute and Adjunct Professor of Basic Sciences at The Commonwealth Medical College. He has published more than 120 scientific publications. He currently is also the CEO of the Pennsylvania Drug Discovery Institute.
Chad E. Beyer Promentis Pharmaceuticals Milwaukee, WI (USA)
Dr. Beyer is President & CEO of Promentis Pharmaceuticals, Inc. He has nearly 20 years of experience in the research, discovery and business development of medications aimed to treat CNS and neurological disorders. Previously, Dr. Beyer served as the Head of Neurochemistry at Wyeth Pharmaceuticals in Princeton, NJ. During his career at Wyeth, Dr. Beyer holds a Ph.D. in Neuropharmacology from LSU Medical Center and an MBA from the Rutgers Business School. Notably, Dr. Beyer has authored more than 70 manuscripts, 3 patents, and co-edited "Next Generation Antidepressants." Dr. Beyer is also an adjunct faculty member at Thomas Jefferson University in Philadelphia where he teaches "Bioventure Management", a class focused on the business of doing science.